JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes | Journal of the American College of Cardiology
Algorithm for switching between oral P2Y12 inhibitors in the acute... | Download Scientific Diagram
Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. | Semantic Scholar
Dual antiplatelet therapy for acute coronary syndromes: How long to continue? | Cleveland Clinic Journal of Medicine
Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial
CCU - ANTI-PLATELET DRUGS #CCU_DRUG 🔹Clopidogrel,... | Facebook
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction by Dr. Vaibhav Yawalkar MD, DM Cardiology | PPT
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial | Trials | Full Text
Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients with acute coronary syndrome - Ya-Ru Zhang, Zheng-Kai Xue, Kang-Yin Chen, Ling-Xia Xu, Wei-Ding Wang, Hua-Yue Tao, Tong-
Ticagrelor (Brilinta) for Secondary Prevention of Thrombotic Events Following Acute Coronary Syndrome | AAFP
Presentation Title
Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study | BMC Cardiovascular Disorders
The impact of clinical and genetic factors on ticagrelor and clopidogrel antiplatelet therapy | Pharmacogenomics
SOLACI | Latin American Society of Interventional Cardiology
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update | Clinical Pharmacokinetics
Pretreatment with P2Y12 Inhibitor in Patients with Acute Coronary Syndromes - American College of Cardiology
Antiplatelet therapy for STEMI - ppt download
BRILINTA - Hematology Advisor
Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study | BMJ Open
Transition between ticagrelor and two different doses of clopidogrel at hospital discharge in patients with acute coronary syndrome submitted to percutaneous coronary intervention - ScienceDirect
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association
